Cerevel Therapeutics Holdings, Inc. Quarterly Current Ratio in % from Q1 2021 to Q1 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Cerevel Therapeutics Holdings, Inc. quarterly Current Ratio history and growth rate from Q1 2021 to Q1 2024.
  • Cerevel Therapeutics Holdings, Inc. Current Ratio for the quarter ending March 31, 2024 was 1.03K %, a 20.8% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q1 2024 1.03K -271 -20.8% Mar 31, 2024
Q4 2023 1.1K -237 -17.8% Dec 31, 2023
Q3 2023 1.14K -234 -17.1% Sep 30, 2023
Q2 2023 1.34K -79.6 -5.61% Jun 30, 2023
Q1 2023 1.3K -248 -16% Mar 31, 2023
Q4 2022 1.33K -80.2 -5.67% Dec 31, 2022
Q3 2022 1.37K -39.7 -2.81% Sep 30, 2022
Q2 2022 1.42K +297 +26.5% Jun 30, 2022
Q1 2022 1.55K +438 +39.4% Mar 31, 2022
Q4 2021 1.41K Dec 31, 2021
Q3 2021 1.41K Sep 30, 2021
Q2 2021 1.12K Jun 30, 2021
Q1 2021 1.11K Mar 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.